Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pamela C, Kibsey"'
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 23, Iss 4, Pp 170-172 (2012)
BACKGROUND/OBJECTIVE: Patients admitted to hospital during the ‘after hours’ (weekends and evenings) may be at increased risk for adverse outcome. The objective of the present study was to assess whether community-onset bloodstream infections pre
Externí odkaz:
https://doaj.org/article/4cc0b241dfc24feaa2aefe185e5667ea
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 3, Iss 6, Pp 299-306 (1992)
A DNA probe encoding the Pseudomonas aeruginosa pilin gene has been developed in the authors’ laboratory and has been shown to be a useful epidemiological tool. In the present study this technology, together with other typing methods, has been used
Externí odkaz:
https://doaj.org/article/7ffb9d28594d431594eeda51f309f50a
Autor:
Peter, Phillips, Eleni, Galanis, Laura, MacDougall, Mei Y, Chong, Robert, Balshaw, Victoria J, Cook, William, Bowie, Theodore, Steiner, Linda, Hoang, Muhammad, Morshed, Wayne, Ghesquiere, David M, Forrest, Diane, Roscoe, Patrick, Doyle, Pamela C, Kibsey, Thomas, Connolly, Yazdan, Mirzanejad, Darby, Thompson, Murray, Fyfe
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 60(9)
Cryptococcus gattii (Cg) infection emerged in British Columbia in 1999. A longitudinal, clinical description of patients has not been reported.Medical records were reviewed for Cg patients identified through surveillance (1999-2007). Risk factors for
Publikováno v:
The Canadian journal of urology. 16(2)
Intravesical Bacillus Calmette-Guérin (BCG) is widely used as an adjuvant therapy in the treatment of superficial bladder cancer. BCG is administered as a live, attenuated form of Mycobacterium bovis, and acts as an immunomodulary agent to delay tum
Publikováno v:
Annals of internal medicine. 101(4)
Excerpt To the editor: We compliment Dienstag and colleagues (1) on their timely study of the use of hepatitis B vaccine in hospital personnel. With a 97% seroconversion rate, one could reasonably ...